Dual role of the ELK3-CYFIP2 axis regulates actin dynamics and immune responses of triple-negative breast cancer during oncogenesis

被引：0
|
作者：
Choi, Seung Hee [1 ]
Ryu, Ki Seo [1 ]
Park, Kyung-Soon [1 ]
Jang, Hye Jung [1 ]
机构：
[1] CHA Univ, Pochon, South Korea
来源：
JOURNAL OF IMMUNOLOGY | 2024年 / 212卷 / 01期
基金：
新加坡国家研究基金会;
关键词：
D O I：
10.4049/jimmunol.212.supp.0732.7489
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis
    Chen, Danyang
    Zeng, Shanshan
    Qiu, Huisi
    Yang, Mingqiang
    Lin, Xin
    Lv, Xinwu
    Li, Pan
    Weng, Shaojuan
    Kou, Siyue
    Luo, Kai
    Liu, Zongcai
    Yi, Yanmei
    Liu, Hao
    CELLULAR SIGNALLING, 2024, 117
  • [32] ASH2L plays a role in triple-negative breast cancer cells through the control of histone H3 lysine 4 methylation
    Ishimura, Akihiko
    Terashima, Minoru
    Takino, Takahisa
    Suzuki, Takeshi
    CANCER SCIENCE, 2024, 115 : 226 - 226
  • [33] Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality
    Zhang, Wenfeng
    Xia, Ding
    Li, Zhangyun
    Zhou, Tao
    Chen, Tingting
    Wu, Zhengping
    Zhou, Weihua
    Li, Zilun
    Li, Longkun
    Xu, Jie
    CELL DEATH & DISEASE, 2019, 10 (8)
  • [34] Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality
    Wenfeng Zhang
    Ding Xia
    Zhangyun Li
    Tao Zhou
    Tingting Chen
    Zhengping Wu
    Weihua Zhou
    Zilun Li
    Longkun Li
    Jie Xu
    Cell Death & Disease, 10
  • [35] HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling
    Bai, Jie
    Chen, Wei-Bin
    Zhang, Xiao-Yu
    Kang, Xiao-Ning
    Jin, Li-Jun
    Zhang, Hui
    Wang, Zun-Yi
    WORLD JOURNAL OF STEM CELLS, 2020, 12 (01): : 87 - 99
  • [36] A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer
    Zhou, Zhuoxin
    Si, Yingnan
    Zhang, Jiashuai
    Chen, Kai
    George, Ashley
    Kim, Seulhee
    Zhou, Lufang
    Liu, Xiaoguang
    CANCER RESEARCH, 2024, 84 (22) : 3848 - 3863
  • [37] Isotoosendanin inhibits triple-negative breast cancer metastasis by reducing mitochondrial fission and lamellipodia formation regulated by the Smad2/3-GOT2-MYH9 signaling axis
    Zhang, Jing-nan
    Zhang, Ze
    Huang, Zhen-lin
    Guo, Qian
    Wu, Ze-qi
    Ke, Chuang
    Lu, Bin
    Wang, Zheng-tao
    Ji, Li-li
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (12) : 2672 - 2683
  • [38] NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells
    Miano, Carmen
    Morselli, Alessandra
    Pontis, Francesca
    Bongiovanni, Chiara
    Sacchi, Francesca
    Da Pra, Silvia
    Romaniello, Donatella
    Tassinari, Riccardo
    Sgarzi, Michela
    Pantano, Elvira
    Ventura, Carlo
    Lauriola, Mattia
    D'Uva, Gabriele
    CANCERS, 2022, 14 (07)
  • [39] Methoxyhispolon Methyl Ether, a Hispolon Analog, Thwarts the SRC/STAT3/BCL-2 Axis to Provoke Human Triple-Negative Breast Cancer Cell Apoptosis In Vitro
    Liao, Chih-Pin
    Hsieh, Ya-Chu
    Lu, Chien-Hsing
    Dai, Wen-Chi
    Yang, Wei-Ting
    Cheng, Kur-Ta
    Ramani, Modukuri V.
    Subbaraju, Gottumukkala V.
    Chang, Chia-Che
    BIOMEDICINES, 2023, 11 (10)
  • [40] eNAMPT/Ac-STAT3/DIRAS2 Axis Promotes Development and Cancer Stemness in Triple-Negative Breast Cancer by Enhancing Cytokine Crosstalk Between Tumor-Associated Macrophages and Cancer Cells
    Zhang, Lifen
    Wang, Lu
    Xu, Ziyao
    Zhang, Xingmei
    Guan, Shaoyu
    Liu, Zhe
    Gu, Shanzhi
    Zhao, Lin
    Bai, Weichao
    Li, Tian
    Zhao, Xinhan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2025, 21 (05): : 2027 - 2047
12345